Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer

被引:74
作者
Wheeler, Cosette Marie [1 ,2 ,3 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87106 USA
[2] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Obstet & Gynecol, Albuquerque, NM 87106 USA
[3] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept House Prevent Epidemiol, Albuquerque, NM 87106 USA
关键词
HPV; Natural history of HPV infection; Abnormal cervical cytology; Abnormal cervical histology; Cervical intraepithelial neoplasia; HPV vaccination and screening;
D O I
10.1016/j.ogc.2008.09.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Over 100 human papillomavirus (HPV) types have been identified to date, of which over 40 infect the genital tract, primarily through sexual transmission. The many different genital HPV types appear to infect, resolve, or persist, and cause abnormal cytology and cervical intraepithelial neoplasia. Several cofactors have been associated with HPV persistence and lesion progression, including smoking, long-term oral contraceptive use, other sexually transmitted infections, host immunogenetics, and viral factors, such as HPV type and HPV variants. Given the discovery of HPV as the single primary cause of invasive cervical cancer, primary and secondary interventions have been realized, including HPV testing in cervical screening programs and prophylactic HPV vaccines. Because first generation HPV vaccines only target the two most common HPV types found in cervical cancer (HPV 16 and 18), cervical screening programs must continue, and the relative roles of HPV vaccination in young women and HPV testing in older women (alone or in conjunction with cytology) will be determined over the next decades.
引用
收藏
页码:519 / +
页数:19
相关论文
共 92 条
[1]   Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States [J].
Altekruse, SF ;
Lacey, JV ;
Brinton, LA ;
Gravitt, PE ;
Silverberg, SG ;
Barnes, WA ;
Greenberg, MD ;
Hadjimichael, OC ;
McGowan, L ;
Mortel, R ;
Schwartz, PE ;
Hildesheim, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) :657-663
[2]   Effective cervical neoplasia detection with a novel optical detection system: A randomized trial [J].
Alvarez, Ronald D. ;
Wright, Thomas C. .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :281-289
[3]   Virologic versus cytologic triage of women with equivocal pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia [J].
Arbyn, M ;
Buntinx, F ;
Van Ranst, M ;
Paraskevaidis, E ;
Martin-Hirsch, P ;
Dillner, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (04) :280-293
[4]   Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer [J].
Arias-Pulido, Hugo ;
Peyton, Cheri L. ;
Joste, Nancy E. ;
Vargas, Hernan ;
Wheeler, Cosette M. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) :1755-1762
[5]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[6]   The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses [J].
Bernard, HU .
JOURNAL OF CLINICAL VIROLOGY, 2005, 32 :S1-S6
[7]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[8]   CHARACTERIZATION OF THE HUMAN PAPILLOMAVIRUS E2 PROTEIN - EVIDENCE OF TRANSACTIVATION AND TRANSREPRESSION IN CERVICAL KERATINOCYTES [J].
BOUVARD, V ;
STOREY, A ;
PIM, D ;
BANKS, L .
EMBO JOURNAL, 1994, 13 (22) :5451-5459
[9]   Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening [J].
Bray, F ;
Loos, AH ;
McCarron, P ;
Weiderpass, E ;
Arbyn, M ;
Moller, H ;
Hakama, M ;
Parkin, DM .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :677-686
[10]   A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women [J].
Brown, DR ;
Shew, ML ;
Qadadri, B ;
Neptune, N ;
Vargas, M ;
Tu, WZ ;
Juliar, BE ;
Breen, TE ;
Fortenberry, JD .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) :182-192